Steeper is proud to announce a new sole distributorship agreement with PectusLab, further strengthening our orthotics offering and expanding access to innovative, evidence-led treatment options for patients across the UK.
 
While Steeper is widely recognised for its leadership in prosthetics, this new partnership reflects our continued commitment to advancing orthotic care and ensuring clinicians and patients benefit from the very latest technology. Through this agreement, Steeper clinicians now have direct access to PectusLab's specialist solutions for the non-surgical treatment of chest wall deformities, including pectus excavatum.
 
PectusLab is a Turkey-based medical technology company dedicated to developing conservative, patient-centred treatments for chest wall conditions. Their products are designed to support early intervention, reduce the need for invasive surgery, and improve both physical outcomes and patient confidence, values that align closely with Steeper’s own approach to care.
 
One of PectusLab's flagship innovations, the Pectus Excavatum Vacuum Bell, is already being used within Steeper clinics. Specialist orthotist Kate Chauhan has been working closely with patients using the device, with early results showing encouraging improvements and positive patient feedback.
 
Commenting on the partnership, Richard Thomas, Steeper Head of Orthotic Product Sales, said, “This partnership with PectusLab is a significant step forward for our orthotics portfolio. It gives our clinicians direct access to proven, cutting-edge technology that can make a real difference to patients’ lives. Ultimately, improving patient outcomes is why we do what we do, and this new relationship will allow us to support more people with effective, non-invasive treatment options.”
 
The sole distributorship with PectusLab reinforces Steeper Group’s long-standing commitment to innovation, clinical excellence, and collaborative partnerships. By expanding our orthotics offering alongside our established prosthetics services, we continue to ensure that patients and clinicians alike benefit from the highest standards of care and the most advanced solutions available.
 
Steeper looks forward to working closely with PectusLab to develop this area of care further and to support improved outcomes for patients now and in the future.

上一篇：Steeper Win Second Supply Chain Excellence Award     下一篇：没有了